The campaign emphasizes the importance of annual cancer screenings with the Queen of Hip-Hop Soul
Hologic, Inc. announced its first national, direct-to-consumer advertising campaign featuring 9-time Grammy-Award winner, artist, actress, and producer Mary J. Blige, which will debut during Super Bowl LVI on NBC on Sunday, February 13. The campaign, “Her Health is Her Wealth,” will continue across NBCU television and digital channels until the Winter Olympics.1
The campaign details Blige’s busy, buzzing life as she goes from set to studio to boardroom and beyond, while still making time to prioritize her annual well-woman visit. “I'm a strong believer that a woman's health is her wealth, and I'm proud to participate in this important campaign that puts that message front and center on the world's biggest stage," Blige said. "I want women everywhere to know that real love means putting yourself first and prioritizing your annual screenings."
Cancer screenings declined at a staggering rate last year during the COVID-19 pandemic: 87% for breast cancer and 84% for cervical cancer, making the campaign’s message even more important for women everywhere.2
While cancer affects women of all races and ethnicities, Black and Hispanic women continue to experience significantly larger disparities in cancer screenings, care, treatment, and outcomes. In fact, Black and Hispanic women have the highest rates of cervical cancer incidence in the country. Despite similar breast cancer incidence rates, Black women have a 41% higher death rate than white women.2
"As a leader in women's health, we are keenly aware of the obstacles facing women across the nation when it comes to making their health a priority — during the pandemic and beyond," said Steve MacMillan, chairman, president and CEO of Hologic.1
The “Her Health is Her Wealth” campaign expands beyond broadcasting and includes digital and social pushes to ScreeningsForHer.com, a robust health literacy resource for women to make informed health care decisions and approach their next well-woman exam with confidence. The site will launch alongside the broadcast advertisement and will continue to evolve throughout the year with new tools and resources.
References
Assessing Onclarity HPV assay safety and efficacy for cervical cancer screening
February 21st 2024A recent study evaluated the safety and effectiveness of the Onclarity HPV assay in detecting high-grade cervical disease, presenting findings on its comparability to predicate assays and potential for cost-saving benefits in screening practices.
Read More
Unifying radical hysterectomy classifications with the Querleu-Morrow
February 16th 2024Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.
Read More